Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes

Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes

ABSTRACT Aim Changes in FIB‐4 levels after the initiation of luseogliflozin therapy were compared between patients with type 2 diabetes according to the presence or absence of alcohol consumption. Methods A total of 192 patients with type 2 diabetes who continued luseogliflozin therapy for over 12 m...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiroyuki Ito, Ryota Someya, Tomoko Koyanagi, Chiaki I, Shun Miura, Suzuko Matsumoto, Hideyuki Inoue, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori, Michiko Togane
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Journal of Diabetes Investigation
Subjects:
Alcohol consumption
FIB‐4
Steatotic liver disease
Online Access:https://doi.org/10.1111/jdi.70032
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items